Status:
TERMINATED
Medihoney and Santyl for Burn Injuries
Lead Sponsor:
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborating Sponsors:
Integra LifeSciences Corporation
West Virginia University
Conditions:
Burns
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study is designed to assess the efficacy of MEDIHONEY® Gel with Active leptospermum honey dressing relative to SANTYL® ointment dressing on time to heal, bacterial growth in the wound, patient sa...
Detailed Description
Researchers have examined the usefulness of honey as a treatment for a variety of wounds. Molan outlines some of the benefits of honey in the treatment of wounds, such as its effective antibacterial a...
Eligibility Criteria
Inclusion
- New patient presenting with a partial thickness burn injury in at least two non-contiguous locations of the body.
- Enrollment will occur within 72 hours of sustaining a burn injury.
Exclusion
- Cognitive or language barriers that preclude completion of study measures.
- Have burn injuries exceeding 40% total body surface area (TBSA).
- Have a diagnosis of immunodeficiency or kidney disease.
- Are receiving treatment (e.g., chemotherapy, dialysis) that can create concerns with immunodeficiency or affect healing.
- Are pregnant.
Key Trial Info
Start Date :
March 15 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2016
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT02250183
Start Date
March 15 2014
End Date
August 18 2016
Last Update
May 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Pennsylvania Hospital Burn Center
Pittsburgh, Pennsylvania, United States, 15224